Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Update to Johnson & Johnson PFA platform gains FDA approval
The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.
FDA approves Bayer's finerenone to treat wide range of heart failure patients
Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.
FDA details multiple Class I recalls for Edwards Lifesciences surgical devices
Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.
CMS proposes Medicare coverage for renal denervation
This proposal, if finalized, would dramatically increase patient access to renal denervation. Both Recor Medical and Medtronic have shared their excitement over the news.
ASE shares new recommendations for evaluating LV diastolic function, HFpEF
The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

Keto diet linked to potential nutritional, cardiovascular issues—do risks outweigh benefits?

Is following a keto-like diet good for a person's health? The team behind this latest analysis reviewed years of research, sharing their findings in Frontiers in Nutrition.

Most AFib patients underestimate their bleeding risk

Researchers aimed to see how many AFib patients on OACs truly understood their risk of a major bleeding event.

Empagliflozin gains FDA approval as treatment for adult HFrEF patients

The FDA’s decision was based largely on results from a clinical trial that included more than 3,700 heart failure patients with a left ventricular ejection fraction of 40% or less.

LAAO outcomes significantly worse among women

Researchers tracked data from more than 49,000 patients who underwent LAAO from January 2016 to June 2019.

COVID booster shots will become available in September

COVID-19 booster shots from Pfizer-BioNTech and Moderna will be available starting the week of September 20, the White House announced.

How recent marijuana use impacts PCI outcomes

Cerebrovascular accidents following PCI appear to be more common when the patient has a history of recent marijuana use.

Catheter ablation boosts AFib outcomes, new meta-analysis confirms

Ablation was associated with a 67% reduction in all-cause hospitalizations compared to medication alone.

Managed care programs help heart attack survivors stay alive and healthy

“Our study demonstrates that a centrally guided and well-designed healthcare policy may have a real and substantial impact on a patient’s prognosis over a relatively short period of time,” researchers said.

Clinical

Update to Johnson & Johnson PFA platform gains FDA approval

FDA approves Bayer's finerenone to treat wide range of heart failure patients

FDA details multiple Class I recalls for Edwards Lifesciences surgical devices

CMS proposes Medicare coverage for renal denervation

ASE shares new recommendations for evaluating LV diastolic function, HFpEF